000 01186 a2200277 4500
005 20250515172333.0
264 0 _c20100929
008 201009s 0 0 eng d
022 _a1876-7605
024 7 _a10.1016/j.jcin.2008.11.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRodriguez, Alfredo E
245 0 0 _aSirolimus-eluting stents or vascular brachytherapy for in-stent restenosis after 3-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial: a call for caution?
_h[electronic resource]
260 _bJACC. Cardiovascular interventions
_cJan 2009
300 _a75-6; author reply 76-7 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aBrachytherapy
650 0 4 _aCoronary Restenosis
_xdrug therapy
650 0 4 _aDrug-Eluting Stents
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aSirolimus
_xtherapeutic use
700 1 _aWaksman, Ron
773 0 _tJACC. Cardiovascular interventions
_gvol. 2
_gno. 1
_gp. 75-6; author reply 76-7
856 4 0 _uhttps://doi.org/10.1016/j.jcin.2008.11.001
_zAvailable from publisher's website
999 _c18889409
_d18889409